NCT03517072 Determinants of the Long-Term Success of Bariatric Surgery
| NCT ID | NCT03517072 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Morbid Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-07-31 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-07-31 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The management of obesity is based on a multidisciplinary approach and justifies the use of surgery in patients with the most severe forms. Surgery for obesity or bariatric surgery generally allows rapid and significant weight loss however it is associated with significant risks, and its long-term results remain heterogeneous and unpredictable. Long-term data will clarify the role of different types of bariatric surgery in surgical strategy, improve patient information and identify predictors of failure in order to provide personalised and tailored surgery for each candidate .
Eligibility Criteria
Inclusion Criteria: * Patients who received bariatric surgery 5 years ago. Exclusion Criteria: * Refusal to participate in the study, * Unable to receive informed information, * Unable to participate in the study
Contact & Investigator
François PATTOU, MD,PhD
PRINCIPAL INVESTIGATOR
University Hospital, Lille
Frequently Asked Questions
Who can join the NCT03517072 clinical trial?
This trial is open to participants of all sexes, studying Morbid Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03517072 currently recruiting?
Yes, NCT03517072 is actively recruiting participants. Contact the research team at françois.pattou@chru-lille.fr for enrollment information.
Where is the NCT03517072 trial being conducted?
This trial is being conducted at Arras, France, Boulogne-sur-Mer, France, Lille, France, Valenciennes, France.
Who is sponsoring the NCT03517072 clinical trial?
NCT03517072 is sponsored by University Hospital, Lille. The principal investigator is François PATTOU, MD,PhD at University Hospital, Lille. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.